1 – 43 of 43
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Prevalence and functional impact of parkinsonian signs in older adults from the Good Aging in Skåne study : Parkinsonian signs in older adults
(
- Contribution to journal › Article
- 2021
-
Mark
How to detect late-onset inborn errors of metabolism in patients with movement disorders - A modern diagnostic approach
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?
(
- Contribution to journal › Letter
- 2016
-
Mark
Autosomal dominant Parkinson's disease caused by SNCA duplications.
(
- Contribution to journal › Article
-
Mark
Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials
(
- Contribution to journal › Letter
-
Mark
Cognitive decline and quality of life in incident Parkinson's disease : The role of attention
(
- Contribution to journal › Article
-
Mark
Wilson disease: Acute dystonia during treatment with SSRI or SNRI
2016) XXI World Congress on Parkinson's Disease and Related Disorders In Parkinsonism and Related Disorders 22(Suppl 2). p.140-141(
- Contribution to journal › Published meeting abstract
-
Mark
Tobacco increases dystonia risk but may ameliorate symptoms
2016) XXI World Congress on Parkinson's Disease and Related Disorders In Parkinsonism and Related Disorders 22(Suppl 2). p.137-138(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program.
(
- Contribution to journal › Scientific review
-
Mark
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations
(
- Contribution to journal › Scientific review
-
Mark
The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: A simple grading system.
(
- Contribution to journal › Article
-
Mark
Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement.
(
- Contribution to journal › Article
- 2014
-
Mark
Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries.
(
- Contribution to journal › Article
-
Mark
Women pioneers in basal ganglia surgery
(
- Contribution to journal › Scientific review
-
Mark
Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: An international multicenter study.
(
- Contribution to journal › Article
-
Mark
Atypical Friedreich ataxia in patients with FXN p.R165P point mutation or comorbid hemochromatosis.
(
- Contribution to journal › Article
-
Mark
Autosomal dominant cerebellar ataxia with slow ocular saccades, neuropathy and orthostatism: A novel entity?
(
- Contribution to journal › Article
-
Mark
Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
(
- Contribution to journal › Article
-
Mark
Predictors of Parkinson's disease dementia : towards targeted therapies for a heterogeneous disease
(
- Contribution to journal › Article
- 2013
-
Mark
Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations.
(
- Contribution to journal › Scientific review
- 2012
-
Mark
First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutation.
(
- Contribution to journal › Article
-
Mark
Motor and non-motor predictors of illness-related distress in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
The serotonin system: a potential target for anti-dyskinetic treatments and biomarker discovery.
(
- Contribution to journal › Article
-
Mark
Genotype–phenotype correlations in THAP1 dystonia: Molecular foundations and description of new cases
(
- Contribution to journal › Article
-
Mark
Synucleinopathies from bench to bedside.
(
- Contribution to journal › Article
- 2011
-
Mark
Parkinson's disease: The non-motor issues
(
- Contribution to journal › Scientific review
-
Mark
Human leukocyte antigen variation and Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
An African-American family with dystonia.
(
- Contribution to journal › Article
- 2009
-
Mark
Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus?
(
- Contribution to journal › Article
-
Mark
Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia.
(
- Contribution to journal › Article
-
Mark
A Swedish family with de novo alpha-synuclein A53T mutation: Evidence for early cortical dysfunction.
(
- Contribution to journal › Article
-
Mark
Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Rodent models of treatment-induced motor complications in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The Parkinson’s Disease Activities of Daily Living Scale (PADLS) revisited.
2009) World Congress on Parkinson’s Disease and Related Disorders In Parkinsonism and Related Disorders 15(S2). p.62-62(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Functional balance performance in patients with Parkinson's disease after long-term treatment with subthalamic nucleus high-frequency stimulation
(
- Contribution to journal › Article
- 2007
-
Mark
Fulfilment of patients' goals after thalamic deep brain stimulation: A follow-up study.
(
- Contribution to journal › Article
-
Mark
The "Lister family": An extended pedigree with alpha-synuclein multiplications and Parkinson's disease.
2007) XVII WFN World Congress on Parkinson's Disease and Related Disorders, 2007 In Parkinsonism & Related Disorders 13(supplement 2). p.95-96(
- Contribution to journal › Published meeting abstract
-
Mark
L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
(
- Contribution to journal › Article
- 2006
-
Mark
Estimating the value of novel interventions for Parkinson's disease: An early decision-making model with application to dopamine cell replacement.
(
- Contribution to journal › Article
- 2004
-
Mark
Harnessing endogenous stem cells to treat neurodegenerative disorders of the basal ganglia.
(
- Contribution to journal › Article
-
Mark
Quality of life and pain in Parkinson's disease: a controlled cross-sectional study
(
- Contribution to journal › Article
- 2003
-
Mark
International use of health status questionnaires in Parkinson's disease: translation is not enough.
(
- Contribution to journal › Article